Literature DB >> 13227604

Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. IV. Effects of prolonged administration of heparin on serum lipids in idiopathic hyperlipemia.

W F LEVER, F S HERBST, N A HURLEY.   

Abstract

Entities:  

Keywords:  BLOOD; CHOLESTEROL/in blood; HEPARIN/therapeutic use; LIPIDS/in blood; LIPOIDOSIS

Mesh：

Substances：

Year:  1955        PMID： 13227604     DOI： 10.1001/archderm.1955.01540260008003

Source DB:  PubMed          Journal:  AMA Arch Derm        ISSN： 0096-5359


× No keyword cloud information.
  8 in total

1.  Effects of heparin on the lipoproteins in hyperlipemia; electrophoretic study of the serum alpha and beta lipoproteins after their separation by fractionation of the plasma proteins or ultracentrifugal flotation.

Authors:  F S HERBST; W F LEVER; M E LYONS; N A HURLEY
Journal:  J Clin Invest       Date:  1955-04       Impact factor: 14.808

2.  Human hyperlipaemia and hypercholesterolaemia: rapid correction with a sulphated polymannuronide.

Authors:  P CONSTANTINIDES; C JOHNSON; B M FAHRNI; R NAKASHIMA; H W McINTOSH
Journal:  Br Med J       Date:  1960-02-20

3.  Idiopathic hyperlipaemia: report of a case studied with radioactive iodine-labelled fat.

Authors:  K S HOLT
Journal:  Arch Dis Child       Date:  1957-04       Impact factor: 3.791

4.  [Heparin therapy and clinical manifestations of idiopathic hyperlipemic xanthomatosis].

Authors:  R HAENSCH
Journal:  Arch Klin Exp Dermatol       Date:  1958

5.  [Activation of proteolysis in human blood and skin by heparins].

Authors:  G STUTTGEN; N HOFMANN; W SIMMICH
Journal:  Klin Wochenschr       Date:  1957-12-01

6.  [Studies on Knüchel's seroreaction in psoriasis].

Authors:  C EBERHARTINGER; F REINHARDT
Journal:  Arch Klin Exp Dermatol       Date:  1956

7.  [Hyperlipemic xanthomatosis and its treatment with heparin].

Authors:  A MATRAS
Journal:  Arch Klin Exp Dermatol       Date:  1956

8.  Heparan sulfate proteoglycans present PCSK9 to the LDL receptor.

Authors:  Camilla Gustafsen; Ditte Olsen; Joachim Vilstrup; Signe Lund; Anika Reinhardt; Niels Wellner; Torben Larsen; Christian B F Andersen; Kathrin Weyer; Jin-Ping Li; Peter H Seeberger; Søren Thirup; Peder Madsen; Simon Glerup
Journal:  Nat Commun       Date:  2017-09-11       Impact factor: 14.919
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.